Fredun Pharmaceuticals share price rose over 3.5% following strong Q1 FY27 results, with net profit increasing 94.1% YoY to ₹13.13 crore. Revenue surged 90.7% YoY to ₹227.75 crore, while total expenses increased primarily due to rising raw material costs and other factors.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.